BigHat Biosciences secures $75M Series C to advance AI-designed protein therapeutics. Total funding reaches $223M. Discover ...

FDA approves Welireg and Lenvima combination for advanced renal cell carcinoma. Learn about this breakthrough treatment for ...

Addex Therapeutics regains full global rights to GABAB PAM portfolio from Indivior. Collaboration termination follows ...

XtalPi files FDA IND application for KQTD-126, a gut-restricted pan-TRK inhibitor for chronic intestinal pain. First-in-class ...

Beijing-based InnoCare Pharma (HKEX: 09969) has entered a strategic research collaboration and license agreement with Eli Lilly and Company (NYSE: LLY)... H. Lundbeck A/S will relocate its US ...

Celldex reports positive Phase 3 results for barzolvolimab in chronic urticaria, meeting primary endpoints. Read the ...

Earendil Labs partners with Genentech for AI-designed bispecific antibodies in oncology. $1.5B+ deal includes $55M upfront payment and milestone targets.

Siemens Healthineers and Novo collaborate to expand non-invasive blood-based testing for MASLD and MASH. Learn about this healthcare partnership.

FDA approves Elevar's Lyrfigtu (lirafugratinib) for previously treated cholangiocarcinoma with FGFR2 fusion. Learn about this breakthrough cancer treatment.

Otsuka's ulefnersen becomes first drug to meet primary endpoint in placebo-controlled FUS-ALS trial, targeting rare genetic ...

Waltham, Massachusetts-based Pretzel Therapeutics announced receipt of US FDA Fast Track Designation for PX578, a central nervous system-penetrant small molecule activator of mitochondrial DNA ...

Eli Lilly partners with Beijing-based InnoCare Pharma in $3.25B strategic collaboration for oncology and autoimmune disease ...